BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2791499)

  • 1. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone.
    Molinari G; Bandelloni R; Paglia P; Debbia E; Schito GC
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):53S-56S. PubMed ID: 2791499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro assessment of the postantibiotic effect of lomefloxacin against gram-positive and gram-negative pathogens.
    Debbia EA; Pesce A; Schito GC
    Am J Med; 1992 Apr; 92(4A):45S-47S. PubMed ID: 1316070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of lomefloxacin (NY-198 or SC 47111).
    Shah PM; Müller S; Kipp J; Stille W
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):97S-101S. PubMed ID: 2791506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials.
    Qadri SM; Lee GC; Ellis ME
    Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis.
    DiVincenzo CA; Shatzer KL; Venezio FR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):13S-16S. PubMed ID: 2507220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of lomefloxacin (SC-47111) and other quinolones.
    Sun ZM; Maskell JP; Sehgal SC; Williams JD
    Infection; 1989; 17(3):165-7. PubMed ID: 2737760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria.
    Hoban D; Grabowski M; Koss J; Weselowski V
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
    Sonstein SA; Dahlgren J
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa.
    Rossolini GM; Valentini S; Satta G
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):57S-64S. PubMed ID: 2507221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance.
    Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV
    Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela.
    Torres JR
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina.
    Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
    Cornaglia G; Ligozzi M; Pelosi E; Canepari P; Fontana R
    J Chemother; 1989 Apr; 1(2):84-90. PubMed ID: 2786558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of lomefloxacin.
    Leigh DA; Tait S; Walsh B
    J Antimicrob Chemother; 1991 May; 27(5):589-98. PubMed ID: 1885417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro evaluation of lomefloxacin].
    Dette GA; Knothe H
    Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
    Wright DN; Saxon B; Matsen JM
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial and plasmid curing activity of lomefloxacin in vitro.
    Derlot E; Poyart-Salmeron C; Courvalin P
    Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1048-52. PubMed ID: 2515963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 20. Lomefloxacin: microbiologic assessment and unique properties.
    Mayer KH; Ellal JA
    Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.